European Obesity Market To Liven Up After CHMP Backs Saxenda
This article was originally published in The Pink Sheet Daily
Executive Summary
Two new antibiotics, Sivextro and Orbactiv, and a rapidly reversible platelet aggregation inhibitor Kengrexal were also among new drugs backed by Europe’s top advisory panel after CHMP’s first meeting of 2015.